TopNewsOn

Results for “prostate cancer”

Dual-purpose polymer dots could combine bioimaging and light-triggered cell death in one material

A research team led by professor Youhei Takeda at the University of Osaka, in collaboration with professor Zachary M. Hudson at the University of British Columbia (UBC) in Canada, has developed a polymer material that combines fluorescent cell imaging with the potential to kill cancer cells when activated by light. The material could offer a simpler approach to developing "nanotheranostic" technologies, which bring disease imaging and treatment together in a single platform.

Phys.org · 22h ago
How microbes make drug-like chemicals without damaging themselves

University of Michigan researchers have discovered a mechanism that enables microscopic organisms like bacteria and fungi to produce drug-like molecules—compounds that can fight infections or kill cancer cells—without damaging themselves.

Phys.org · 22h ago
How a tiny chemical mark on a protein can be placed to double gene activity

Tiny chemical marks on histones—the proteins that package our DNA—can profoundly influence gene activity without changing the underlying DNA sequence. One such mark, known as histone acetylation, plays a crucial role in regulating gene expression and is frequently disrupted in diseases such as cancer. Researchers, however, wondered how the enzymes responsible for adding these marks know exactly where to place them.

Phys.org · 23h ago
The surprising cancer connection at the heart of Alzheimer's

People say "the body keeps score"—but it might be more accurate to say our neurons do. In healthy people, neurons accumulate about 17 single-nucleotide variants each year, a pattern that holds from birth through a person's final years, according to research from HHMI investigator Chris Walsh and others.

Medical Xpress · 23h ago
Light-activated nanoparticles may help treat head and neck cancer

For patients with head and neck cancer, treatment can come at a high cost to their quality of life, affecting their ability to speak, swallow and even breathe due to invasive procedures. Now, Penn State researchers have developed a light-activated nanoparticle system with the long-term goal of shrinking tumors while limiting exposure to healthy tissue and improving patients' quality of life after cancer treatment. Penn State has licensed the technology to Illuminate Therapeutics, which is advancing its preclinical development.

Phys.org · 23h ago
Newly discovered mechanism may help ovarian cancer cells silence tumor-suppressor genes

Researchers at Umeå University have discovered how chemical marks on RNA control a DNA methylation enzyme and contribute to the silencing of tumor-suppressor genes in ovarian cancer cells. The findings provide new insights into the disease and may, in the long term, contribute to the development of new treatment strategies for high-grade serous ovarian carcinoma.

Medical Xpress · Nov 19
Howard-era minister Sharman Stone dies via voluntary assisted dying, aged 75

The former Liberal MP had fought a long battle against glioblastoma, an aggressive form of brain cancer Former Liberal MP Sharman Stone has died via voluntary assisted dying after spending much of her political career advocating that people should have autonomy over their bodies. Dr Stone died aged 75 on Wednesday surrounded by family after a long fight against glioblastoma, an aggressive form of brain cancer. Continue reading...

The Guardian · Nov 19
Commonly mutated gene could be a therapeutic target in sarcoma

Researchers at The University of Texas MD Anderson Cancer Center have discovered that sarcomas lacking the ATRX gene tend to be more aggressive and may be particularly vulnerable to a class of targeted therapies known as TEAD inhibitors. The findings identify ATRX loss as both a marker of poor prognosis and a potential therapeutic target.

Medical Xpress · Nov 19
Sasse to release memoir on his life, family amid cancer battle

Former Sen. Ben Sasse (R-Neb.) announced Thursday he will release a new memoir reflecting on his life and the passage of time next year, which he penned alongside his daughter amid his battle with Stage 4 pancreatic cancer. “Fighting cancer is… uh…not as fun as you might expect, but…working on a book with your kid…

The Hill · Nov 19
Novel CAR-T platform uses radiation-activated switch to destroy tumors more effectively

Engineering patients' own immune cells to find and destroy cancer using chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of blood cancers. However, its use is limited in solid tumors because the immunosuppressive tumor microenvironment prevents CAR T-cell entry into the tumor and causes cells that enter to become exhausted.

Medical Xpress · Nov 19
Children exposed to more radiation from medical scans may face higher brain tumor risk

A new large study led by UC Davis and UC San Francisco researchers has found that higher cumulative radiation dose to the brain from medical imaging during childhood is linked to a greater brain tumor risk in children and adolescents. Brain tumors are the second most common childhood cancers and are the leading cause of cancer death among children and adolescents.

Medical Xpress · Nov 19
Predictive biomarker for liver cancer associated with survival outcomes, effectiveness of systemic therapy

Liver cancer was the sixth most common cancer and the third leading cause of cancer-related deaths worldwide in 2022, with hepatocellular carcinoma (HCC) as the most common histological subtype, accounting for approximately 90% of liver cancers. Despite this, biomarkers that predict survival and therapeutic response to atezolizumab plus bevacizumab (Atezo/Bev), a type of systemic therapy in HCC management, have yet to be established in unresectable HCC, in which the tumor cannot be safely treated via surgical removal.

Medical Xpress · Nov 19
Researchers find two understudied 'forever chemicals' raise liver cancer risk

A first-of-its-kind USC study links two little-studied "forever chemicals" to liver cancer, with the greatest risk in those already genetically susceptible to fatty liver disease. The study, published in Environmental Health Perspectives, finds that two per- and polyfluoroalkyl substances (PFAS), also known as "forever chemicals," are associated with a significantly higher risk of liver cancer, with the strongest effects in people genetically predisposed to metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease.

Medical Xpress · Nov 19
Italian Court Sentences Parents for Refusing Cancer Treatment for Late Teenage Son

An Italian court in the town of Vicenza on Wednesday sentenced two parents to two years in prison on involuntary manslaughter charges for refusing adequate cancer treatment for their late son. The post Italian Court Sentences Parents for Refusing Cancer Treatment for Late Teenage Son appeared first on Breitbart .

Breitbart · Nov 19
Scientists discover a hidden hereditary form of aggressive prostate cancer

Scientists have discovered a rare inherited mutation in the CDK12 gene linked to aggressive prostate cancer, with all five identified carriers developing metastatic disease between ages 44 and 62. The finding could lead to expanded genetic testing, helping families uncover hidden cancer risks and potentially detect the disease while it is still treatable.

Science Daily · Nov 19
Lilly Buying Spree Surpasses $32B

Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.”  Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses. (Source: Bloomberg)

Bloomberg · Nov 18
MRI advance could help monitor fatty liver disease by revealing enzyme activity

Researchers in Japan have, for the first time, visualized the activity of an important liver enzyme in vivo using an MRI-based approach, potentially providing a new way to detect and monitor fatty liver disease. The condition can progress with few obvious warning signs and, in severe cases, can lead to liver inflammation, fibrosis, cirrhosis and liver cancer.

Medical Xpress · Nov 18
Researchers compare AI tools for analyzing tumor tissue

Researchers at Skoltech, the University of Sharjah in the United Arab Emirates and Tokai University in Japan, together with colleagues, have published an open-access review of computer vision in histopathology. The review examines how algorithms can identify tissue features in lung, breast, colorectal and prostate cancers.

Medical Xpress · Nov 18
An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors

A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA vaccine significantly increases the potency of therapeutic immune cells. The paper is published in the journal Cancer Research.

Medical Xpress · Nov 18
Dual-targeted CAR T-cell therapy shows promise in patients with treatment-resistant multiple myeloma

A first-in-human study by Mass General Brigham Cancer Institute investigators found that a chimeric antigen receptor (CAR) T-cell therapy called TriPRIL reduced or eliminated signs of cancer in 12 of 15 patients with relapsed or refractory multiple myeloma. TriPRIL—short for trimeric APRIL (a proliferation-inducing ligand)—recognizes two proteins on myeloma cells instead of just one. Researchers published their findings in The Lancet.

Medical Xpress · Nov 18
Bacterial toxin produced by E coli leading suspect in rise in bowel cancer among under-50s

Scientists tell Commons committee that exposure to colibactin in early life is a potential driver of early onset colorectal cancer Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer amongs those under 50, MPs have heard. Cases of early onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved. Continue reading...

The Guardian · Nov 18
How cancer cells protect themselves from a toxin they produce

Cancer cells must protect themselves from the harmful substances they produce as they grow. Now, researchers have identified how they neutralize one of these substances, formaldehyde, while keeping another defense against cell death intact. The findings suggest a way to attack both defenses together, and the next step is to find out whether it could become a treatment.

Medical Xpress · Nov 18
Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

Trust apologises after findings on treatment of 20 brain tumour patients under oncologist who retired in 2023 Cancer patients were severely harmed after being given years of unnecessary chemotherapy treatment by an NHS trust, a report has found. Some people were misdiagnosed and given inappropriate courses of treatment, while others were incorrectly told that if they stopped chemotherapy they would die, according to a Royal College of Physicians (RCP) report. Continue reading...

The Guardian · Nov 18
Study finds some BRCA2 gene changes carry lower breast cancer risk

Mayo Clinic researchers, in a study published in Nature Communications, have identified a group of BRCA2 gene variants associated with a moderate risk of breast cancer, a finding that could help health care teams better assess a person's cancer risk and personalize care.

Medical Xpress · Nov 18
Thom Velde, Former AMC Theatres Executive, Dies at 83

Thomas Velde, who served as head film buyer at AMC Theatres during his 27 years at the exhibitor, died Oct. 31. He was 83. Velde died of cancer at his home in Rancho Mirage, Calif.. For 27 years, he worked at AMC Theatres, where he negotiated film agreements with domestic and international studios while also […]

Variety · Nov 17